Literature DB >> 984103

Virucidal effect of certain chemical contraceptives on Type 2 herpesvirus.

B Singh, B Posti, J C Cutler.   

Abstract

The virucidal effect of several chemical contraceptives was investigated and the findings are rrported. The supension of Type 2 herpes simplex virus, containing 10(6) to 10(7) tissue culture infectious doses per 0.1 ml., was inactivated on exposure to five different chemical contraceptives. For quantitative estimates of virucidal effect, 10 per cent solutions of these chemical contraceptives were tested with an exposure time of 10 minutes at room temperature. The methods for determination of residual infectivity included both virus assays in cultures of Vero cells and human embryo fibroblasts, as well as the intracranial inoculation of mice. Virus infectivity decreased 1,000- to 10,000-fold after contact with chemical contraceptives, indicating a substantial virucidal effect.

Entities:  

Keywords:  Animals, Laboratory; Clinical Research; Contraceptive Agents, Female; Examinations And Diagnoses; In Vitro; Laboratory Examinations And Diagnoses; Laboratory Procedures; Research Methodology; Spermicidal Contraceptive Agents; Vaginal Cream; Vaginal Jelly

Mesh:

Substances:

Year:  1976        PMID: 984103     DOI: 10.1016/0002-9378(76)90630-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Inactivation of herpes simplex viruses by nonionic surfactants.

Authors:  S S Asculai; M T Weis; M W Rancourt; A B Kupferberg
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

2.  Nonoxinol 9 and HIV infection.

Authors:  D J Jeffries
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

Review 3.  Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review.

Authors:  L C d'Oro; F Parazzini; L Naldi; C La Vecchia
Journal:  Genitourin Med       Date:  1994-12

4.  Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro.

Authors:  H Thormar; G Bergsson; E Gunnarsson; G Georgsson; M Witvrouw; O Steingrímsson; E De Clercq; T Kristmundsdóttir
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

5.  Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing.

Authors:  M C Skinner; W E Stamm; M L Lampe
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

6.  Use of high-resolution confocal imaging of the vaginal epithelial microstructure to detect microbicide toxicity.

Authors:  Gracie Vargas; Tuya Shilagard; Rebecca Johnston; Brent Bell; Rachael L Stegall; Kathleen Vincent; Lawrence Stanberry; Massoud Motamedi; Nigel Bourne
Journal:  J Infect Dis       Date:  2009-05-15       Impact factor: 5.226

7.  In vitro activity of nonoxynol 9 on HeLa 229 cells and primary monkey cervical epithelial cells infected with Chlamydia trachomatis.

Authors:  D L Patton; S K Wang; C C Kuo
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

8.  Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro.

Authors:  S Benes; W M McCormack
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

9.  In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.

Authors:  Brigitte E Beer; Gustavo F Doncel; Fred C Krebs; Robin J Shattock; Patricia S Fletcher; Robert W Buckheit; Karen Watson; Charlene S Dezzutti; James E Cummins; Ena Bromley; Nicola Richardson-Harman; Luke A Pallansch; Carol Lackman-Smith; Clay Osterling; Marie Mankowski; Shendra R Miller; Bradley J Catalone; Patricia A Welsh; Mary K Howett; Brian Wigdahl; Jim A Turpin; Patricia Reichelderfer
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.